Caspase-1 Dependent IL-1β Secretion Is Critical for Host Defense in a Mouse Model of Chlamydia pneumoniae Lung Infection

Chlamydia pneumoniae (CP) is an important human pathogen that causes atypical pneumonia and is associated with various chronic inflammatory disorders. Caspase-1 is a key component of the ‘inflammasome’, and is required to cleave pro-IL-1β to bioactive IL-1β. Here we demonstrate for the first time a critical requirement for IL-1β in response to CP infection. Caspase-1−/− mice exhibit delayed cytokine production, defective clearance of pulmonary bacteria and higher mortality in response to CP infection. Alveolar macrophages harbored increased bacterial numbers due to reduced iNOS levels in Caspase-1−/− mice. Pharmacological blockade of the IL-1 receptor in CP infected wild-type mice phenocopies Caspase-1-deficient mice, and administration of recombinant IL-1β rescues CP infected Caspase-1−/− mice from mortality, indicating that IL-1β secretion is crucial for host immune defense against CP lung infection. In vitro investigation reveals that CP-induced IL-1β secretion by macrophages requires TLR2/MyD88 and NLRP3/ASC/Caspase-1 signaling. Entry into the cell by CP and new protein synthesis by CP are required for inflammasome activation. Neither ROS nor cathepsin was required for CP infection induced inflammasome activation. Interestingly, Caspase-1 activation during CP infection occurs with mitochondrial dysfunction indicating a possible mechanism involving the mitochondria for CP-induced inflammasome activation.

[1]  S. Ryter,et al.  Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome. , 2011, Nature immunology.

[2]  E. Latz The inflammasomes: mechanisms of activation and function. , 2010, Current opinion in immunology.

[3]  D. Golenbock,et al.  Inflammasomes: too big to miss. , 2009, The Journal of clinical investigation.

[4]  H. Wigzell,et al.  Role of innate and adaptive immunity in the outcome of primary infection with Chlamydia pneumoniae, as analyzed in genetically modified mice. , 1999, Journal of immunology.

[5]  Nicholas J Alp,et al.  Role of Chlamydia pneumoniae in atherosclerosis. , 2008, Clinical science.

[6]  R. Nurieva,et al.  Critical regulation of early Th17 cell differentiation by interleukin-1 signaling. , 2009, Immunity.

[7]  A. Aderem,et al.  Staphylococcus aureus evades lysozyme-based peptidoglycan digestion that links phagocytosis, inflammasome activation, and IL-1beta secretion. , 2010, Cell host & microbe.

[8]  R. Kamen,et al.  Mice deficient in IL-1β-converting enzyme are defective in production of mature IL-1β and resistant to endotoxic shock , 1995, Cell.

[9]  Egil Lien,et al.  NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals , 2010, Nature.

[10]  D. Orphanidou,et al.  Chlamydophila pneumoniae infection and COPD: more evidence for lack of evidence? , 2009, European journal of internal medicine.

[11]  G. Kroemer,et al.  Mitochondrial membrane permeabilization is a critical step of lysosome-initiated apoptosis induced by hydroxychloroquine , 2003, Oncogene.

[12]  H. Wigzell,et al.  The role of IFN-γ in the outcome of chlamydial infection , 2002 .

[13]  F. Blasi,et al.  Chlamydophila pneumoniae. , 2020, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[14]  J. Tschopp,et al.  Activation of the NLRP3 inflammasome in dendritic cells induces IL-1β–dependent adaptive immunity against tumors , 2009, Nature Medicine.

[15]  G. Kroemer,et al.  Organelle-specific initiation of cell death pathways , 2001, Nature Cell Biology.

[16]  M. Paskind,et al.  Mice deficient in IL-1 beta-converting enzyme are defective in production of mature IL-1 beta and resistant to endotoxic shock. , 1995, Cell.

[17]  H. Wigzell,et al.  The role of IFN-gamma in the outcome of chlamydial infection. , 2002, Current opinion in immunology.

[18]  D. Underhill,et al.  The NOD/RIP2 Pathway Is Essential for Host Defenses Against Chlamydophila pneumoniae Lung Infection , 2009, PLoS pathogens.

[19]  M. Netea,et al.  Listeria monocytogenes-Infected Human Peripheral Blood Mononuclear Cells Produce IL-1β, Depending on Listeriolysin O and NLRP3 , 2009, The Journal of Immunology.

[20]  F. Martinon,et al.  The inflammasomes: guardians of the body. , 2009, Annual review of immunology.

[21]  K. Koelle The impact of climate on the disease dynamics of cholera. , 2009, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[22]  Xi Yang,et al.  Role of toll-like receptors in immune responses to chlamydial infections. , 2008, Current pharmaceutical design.

[23]  V. Levitsky,et al.  Regulation and Role of IFN-γ in the Innate Resistance to Infection with Chlamydia pneumoniae1 , 2000, The Journal of Immunology.

[24]  E. Unanue,et al.  Interleukin 1 is processed and released during apoptosis. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[25]  C. Dinarello,et al.  Immunological and inflammatory functions of the interleukin-1 family. , 2009, Annual review of immunology.

[26]  K. Moore,et al.  NLRP3 inflamasomes are required for atherogenesis and activated by cholesterol crystals that form early in disease , 2010, Nature.

[27]  Xiangmei Zhou,et al.  A role for mitochondria in NLRP3 inflammasome activation , 2011, Nature.

[28]  M. Leinonen,et al.  Growth of Chlamydia pneumoniae in cultured human peripheral blood mononuclear cells and induction of a cytokine response. , 1996, Microbial pathogenesis.

[29]  M. Netea,et al.  Acellular components of Chlamydia pneumoniae stimulate cytokine production in human blood mononuclear cells , 2000, European journal of immunology.

[30]  A. Sher,et al.  Cutting Edge: Caspase-1 Independent IL-1β Production Is Critical for Host Resistance to Mycobacterium tuberculosis and Does Not Require TLR Signaling In Vivo , 2010, The Journal of Immunology.

[31]  M. Su,et al.  Altered cytokine export and apoptosis in mice deficient in interleukin-1 beta converting enzyme. , 1995, Science.

[32]  David A. Williams,et al.  Mouse model of X–linked chronic granulomatous disease, an inherited defect in phagocyte superoxide production , 1995, Nature Genetics.

[33]  Sten Orrenius,et al.  Mitochondria, oxidative stress and cell death , 2007, Apoptosis.

[34]  F. Fend,et al.  Differential involvement of TLR2 and TLR4 in host survival during pulmonary infection with Chlamydia pneumoniae , 2006, European journal of immunology.

[35]  E. S. Fox,et al.  Inhibition of LPS‐mediated activation in rat Kupffer cells by N‐acetylcysteine occurs subsequent to NF‐κB translocation and requires protein synthesis , 1998, Journal of leukocyte biology.

[36]  S. Leppla,et al.  Inflammasome Sensor Nlrp1b-Dependent Resistance to Anthrax Is Mediated by Caspase-1, IL-1 Signaling and Neutrophil Recruitment , 2010, PLoS pathogens.

[37]  Lawrence H. Uricchio,et al.  Inflammasome-Mediated Production of IL-1β Is Required for Neutrophil Recruitment against Staphylococcus aureus In Vivo1 , 2007, The Journal of Immunology.

[38]  J. Rupp,et al.  Imbalanced secretion of IL‐1β and IL‐1RA in Chlamydia pneumoniae-infected mononuclear cells from COPD patients , 2003, European Respiratory Journal.

[39]  G. Núñez,et al.  The inflammasome: a caspase-1-activation platform that regulates immune responses and disease pathogenesis , 2009, Nature Immunology.

[40]  V. Levitsky,et al.  Regulation and role of IFN-gamma in the innate resistance to infection with Chlamydia pneumoniae. , 2000, Journal of immunology.

[41]  J. Catravas,et al.  Molecular mechanisms of iNOS induction by IL-1 beta and IFN-gamma in rat aortic smooth muscle cells. , 2002, American journal of physiology. Cell physiology.

[42]  E. Gold,et al.  Amphiphysin IIm Is Required for Survival of Chlamydia pneumoniae in Macrophages , 2004, The Journal of experimental medicine.

[43]  G. Häcker,et al.  Phagocytosis‐induced apoptosis of macrophages is linked to uptake, killing and degradation of bacteria , 2008, European journal of immunology.

[44]  L. Jacobs,et al.  Chlamydia pneumoniae stimulates IFN-gamma synthesis through MyD88-dependent, TLR2- and TLR4-independent induction of IL-18 release. , 2004, Journal of immunology.

[45]  K. Moore,et al.  The NALP3 inflammasome is involved in the innate immune response to amyloid-β , 2008, Nature Immunology.

[46]  J. Catravas,et al.  Molecular mechanisms of iNOS induction by IL-1β and IFN-γ in rat aortic smooth muscle cells , 2002 .

[47]  E. Lien,et al.  Inflammation and Fibrosis during Chlamydia pneumoniae Infection Is Regulated by IL-1 and the NLRP3/ASC Inflammasome , 2010, The Journal of Immunology.

[48]  J. Carter,et al.  Molecular biology of infectious agents in chronic arthritis. , 2009, Rheumatic diseases clinics of North America.

[49]  Keith D Garlid,et al.  Mitochondrial potassium transport: the K(+) cycle. , 2003, Biochimica et biophysica acta.

[50]  J. Tschopp,et al.  Innate Immune Activation Through Nalp3 Inflammasome Sensing of Asbestos and Silica , 2008, Science.

[51]  C. Dinarello,et al.  Biologic basis for interleukin-1 in disease. , 1996, Blood.

[52]  E. R. Sutherland,et al.  Asthma and atypical bacterial infection. , 2007, Chest.

[53]  D. Ojcius,et al.  Inflammasome-dependent Caspase-1 Activation in Cervical Epithelial Cells Stimulates Growth of the Intracellular Pathogen Chlamydia trachomatis* , 2009, The Journal of Biological Chemistry.

[54]  R. Alsabeh,et al.  MyD88 Is Pivotal for the Early Inflammatory Response and Subsequent Bacterial Clearance and Survival in a Mouse Model of Chlamydia pneumoniae Pneumonia* , 2005, Journal of Biological Chemistry.

[55]  V. Dixit,et al.  Cryopyrin activates the inflammasome in response to toxins and ATP , 2006, Nature.

[56]  S. Leppla,et al.  CA-074Me Protection against Anthrax Lethal Toxin , 2009, Infection and Immunity.